Once for Life

Once for Life

Creating transformational gene and peptide therapies that treat the most prevalent diseases to restore health and renew life

Renova Therapeutics envisions a future in which we’re able to permanently treat chronic diseases with gene and peptide therapies. Right now, we’re developing definitive treatments to restore health to people suffering from some of the most common and devastating chronic conditions in the world: congestive heart failure and type 2 diabetes.

Tell Us Who You Are, And We'll Guide You Through our Site


Latest News:  January 11, 2018 | Renova Therapeutics to present key components of FLOURISH gene therapy trial for the treatment of heart failure at Keystone Symposium

  December 14, 2017 | US FDA grants Fast Track designation to Renova Therapeutics’ RT-100 AC6 gene transfer for the treatment of heart failure

View All News
Subscribe to receive company press releases and announcements